352 related articles for article (PubMed ID: 11012176)
1. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
[TBL] [Abstract][Full Text] [Related]
2. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
3. [Thrombopoietin and megakaryocyte differentiation].
Vainchenker W; Debili N; Norol F; Wendling F
Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin (Mpl-ligand) and the regulation of platelet production.
Cohen-Solal K; Debili N; Vainchenker W; Wendling F
Thromb Haemost; 1997 Jul; 78(1):37-41. PubMed ID: 9198124
[TBL] [Abstract][Full Text] [Related]
6. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
7. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
[TBL] [Abstract][Full Text] [Related]
8. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
9. Stromal-conditioned medium synergizes with thrombopoietin in stimulating megakaryocytopoiesis.
Schattner M; Green D; Cohen I
Stem Cells; 1998; 16(1):61-5. PubMed ID: 9474749
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation.
Vitrat N; Letestu R; Massé A; Lazar V; Vainchenker W; Debili N
Thromb Haemost; 2000 May; 83(5):759-68. PubMed ID: 10823275
[TBL] [Abstract][Full Text] [Related]
11. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
12. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
[TBL] [Abstract][Full Text] [Related]
13. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
Mintern J; Williams N; Jackson H
Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
[TBL] [Abstract][Full Text] [Related]
14. Effects of Mpl ligands on platelet production and function in nonhuman primates.
Harker LA; Marzec UM; Kelly AB
Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand.
Cramer EM; Norol F; Guichard J; Breton-Gorius J; Vainchenker W; Massé JM; Debili N
Blood; 1997 Apr; 89(7):2336-46. PubMed ID: 9116277
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro.
Choi ES; Hokom M; Bartley T; Li YS; Ohashi H; Kato T; Nichol JL; Skrine J; Knudten A; Chen J
Stem Cells; 1995 May; 13(3):317-22. PubMed ID: 7542117
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytes.
Giammona LM; Fuhrken PG; Papoutsakis ET; Miller WM
Br J Haematol; 2006 Nov; 135(4):554-66. PubMed ID: 17054670
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte development and platelet production.
Deutsch VR; Tomer A
Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
[TBL] [Abstract][Full Text] [Related]
19. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo.
Fock EL; Yan F; Pan S; Chong BH
Exp Hematol; 2008 Jan; 36(1):78-92. PubMed ID: 17923245
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution.
Bruno S; Gunetti M; Gammaitoni L; Danè A; Cavalloni G; Sanavio F; Fagioli F; Aglietta M; Piacibello W
Haematologica; 2003 Apr; 88(4):379-87. PubMed ID: 12681964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
